ULBP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.172300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.697000E-01
Normal-vs-Stage2
1.031140E-04
Normal-vs-Stage3
6.160200E-01
Normal-vs-Stage4
1.651160E-01
Stage1-vs-Stage2
2.727800E-01
Stage1-vs-Stage3
7.614400E-01
Stage1-vs-Stage4
3.623600E-01
Stage2-vs-Stage3
5.488000E-01
Stage2-vs-Stage4
8.695800E-01
Stage3-vs-Stage4
3.971400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.620500E-04
Normal-vs-AfricanAmerican
1.207160E-01
Normal-vs-Asian
1.653760E-01
Caucasian-vs-AfricanAmerican
7.144400E-01
Caucasian-vs-Asian
5.099000E-01
AfricanAmerican-vs-Asian
6.939200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.247100E-04
Normal-vs-Female
5.759400E-04
Male-vs-Female
6.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.446400E-01
Normal-vs-Age(41-60Yrs)
1.645320E-04
Normal-vs-Age(61-80Yrs)
1.136420E-03
Normal-vs-Age(81-100Yrs)
4.130000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.350000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.588000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.104400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.348600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.667600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.062800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.685820E-02
Normal-vs-Daily Drinker
3.598600E-01
Normal-vs-Weekly Drinker
2.445400E-01
Normal-vs-Occasional Drinker
2.154100E-02
Normal-vs-Social Drinker
3.149200E-01
Non Drinker-vs-Daily Drinker
1.918850E-01
Non Drinker-vs-Weekly Drinker
5.925400E-01
Non Drinker-vs-Occasional Drinker
4.316600E-01
Non Drinker-vs-Social Drinker
3.399600E-01
Daily Drinker-vs-Weekly Drinker
3.350000E-01
Daily Drinker-vs-Occasional Drinker
2.456000E-01
Daily Drinker-vs-Social Drinker
6.721000E-01
Weekly Drinker-vs-Occasional Drinker
8.391600E-01
Weekly Drinker-vs-Social Drinker
6.255400E-01
Occasional Drinker-vs-Social Drinker
6.562200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.954600E-01
Normal-vs-Grade 2
7.666800E-01
Normal-vs-Grade 3
5.294400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.962200E-03
Grade 1-vs-Grade 3
1.204460E-03
Grade 1-vs-Grade 4
6.954600E-01
Grade 2-vs-Grade 3
8.668600E-01
Grade 2-vs-Grade 4
7.666800E-01
Grade 3-vs-Grade 4
5.294400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.276000E-01
Normal-vs-NonDiabetic
2.042000E-04
Diabetic-vs-NonDiabetic
1.162990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.788200E-01
Normal-vs-NoPancreatitis
1.849300E-04
Pancreatitis-vs-NoPancreatitis
2.476600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.324800E-01
Normal-vs-N1
7.94010000000345E-05
N0-vs-N1
1.218620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.20840000000533E-05
Normal-vs-TP53-NonMutant
6.219400E-04
TP53-Mutant-vs-TP53-NonMutant
3.224300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
